Vergleich

Inhibitors & Compound Libraries

609594 Artikel

pro Seite

Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge Preis
BI-­3406(SOS1-­IN-­2) Inhibitors Other IC DCC-DC39083-100mg

DCChemicals
100 mg Anmelden
Vergleichen
NEO2734 Inhibitors Other IC DCC-DC39097-250mg

DCChemicals
250 mg Anmelden
Vergleichen
MC-­DM1 Inhibitors Other DCC-DC40875-10mg

DCChemicals
10 mg Anmelden
Vergleichen
BI-­3406(SOS1-­IN-­2) Inhibitors Other IC DCC-DC39083-250mg

DCChemicals
250 mg Anmelden
Vergleichen
NEO2734 Inhibitors Other IC DCC-DC39097-1g

DCChemicals
1 g Anmelden
Vergleichen
BI-­3406(SOS1-­IN-­2) Inhibitors Other IC DCC-DC39083-1g

DCChemicals
1 g Anmelden
Vergleichen
DCC-­3014(Vimseltinib) Inhibitors Other IC DCC-DC40860-250mg

DCChemicals
250 mg Anmelden
Vergleichen
DCC-­3014(Vimseltinib) Inhibitors Other IC DCC-DC40860-100mg

DCChemicals
100 mg Anmelden
Vergleichen
DCC-­3014(Vimseltinib) Inhibitors Other IC DCC-DC40860-1g

DCChemicals
1 g Anmelden
Vergleichen
SIRT7 inhibitor 97491 Inhibitors Other IC DCC-DC40782-250mg

DCChemicals
250 mg Anmelden
Vergleichen
SIRT7 inhibitor 97491 Inhibitors Other IC DCC-DC40782-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Pyrrolnitrin Inhibitors Other Pyrrolnitrin is an antibiotic isolated from Pseudomonas pyrrocinia. Pyrrolnitrin shows a broad spectrum of antibiotic activity against fungi, yeast and gram-positive bacteria. DCC-DC40718-10mg

DCChemicals
10 mg Anmelden
Vergleichen
A2793 Inhibitors Other IC DCC-DC41048-250mg

DCChemicals
250 mg Anmelden
Vergleichen
A2793 Inhibitors Other IC DCC-DC41048-100mg

DCChemicals
100 mg Anmelden
Vergleichen
A2793 Inhibitors Other IC DCC-DC41048-1g

DCChemicals
1 g Anmelden
Vergleichen
ERK1/­2 inhibitor 2(ASTX-­029) Inhibitors Other ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity. DCC-DC40360-250mg

DCChemicals
250 mg Anmelden
Vergleichen
ERK1/­2 inhibitor 2(ASTX-­029) Inhibitors Other ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity. DCC-DC40360-100mg

DCChemicals
100 mg Anmelden
Vergleichen
ERK1/­2 inhibitor 2(ASTX-­029) Inhibitors Other ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity. DCC-DC40360-1g

DCChemicals
1 g Anmelden
Vergleichen
DSR-­141562 Inhibitors Other IC, other DCC-DC40977-250mg

DCChemicals
250 mg Anmelden
Vergleichen
DSR-­141562 Inhibitors Other IC, other DCC-DC40977-100mg

DCChemicals
100 mg Anmelden
Vergleichen
DSR-­141562 Inhibitors Other IC, other DCC-DC40977-1g

DCChemicals
1 g Anmelden
Vergleichen
EBOV/­MARV-­IN-­1 Inhibitors Other EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells. DCC-DC41042-250mg

DCChemicals
250 mg Anmelden
Vergleichen
EBOV/­MARV-­IN-­1 Inhibitors Other EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells. DCC-DC41042-100mg

DCChemicals
100 mg Anmelden
Vergleichen
EBOV/­MARV-­IN-­1 Inhibitors Other EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells. DCC-DC41042-1g

DCChemicals
1 g Anmelden
Vergleichen
KRAS inhibitor-­9 Inhibitors Other KRAS inhibitor-9, a potent KRAS inhibitor (Kd=92 μM), blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 binds to KRAS G12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells. DCC-DC41041-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Name Preis
BI-­3406(SOS1-­IN-­2) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
NEO2734 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
MC-­DM1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
BI-­3406(SOS1-­IN-­2) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
NEO2734 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
BI-­3406(SOS1-­IN-­2) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
DCC-­3014(Vimseltinib) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
DCC-­3014(Vimseltinib) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
DCC-­3014(Vimseltinib) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
SIRT7 inhibitor 97491 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
SIRT7 inhibitor 97491 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
Pyrrolnitrin Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. Pyrrolnitrin is an antibiotic isolated from Pseudomonas pyrrocinia. Pyrrolnitrin shows a broad spectrum of antibiotic activity against fungi, yeast and gram-positive bacteria.
Host
ArtNr.
Menge 10 mg
Lieferbar
A2793 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
A2793 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
A2793 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
ERK1/­2 inhibitor 2(ASTX-­029) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity.
Host
ArtNr.
Menge 250 mg
Lieferbar
ERK1/­2 inhibitor 2(ASTX-­029) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity.
Host
ArtNr.
Menge 100 mg
Lieferbar
ERK1/­2 inhibitor 2(ASTX-­029) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity.
Host
ArtNr.
Menge 1 g
Lieferbar
DSR-­141562 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 250 mg
Lieferbar
DSR-­141562 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 100 mg
Lieferbar
DSR-­141562 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 1 g
Lieferbar
EBOV/­MARV-­IN-­1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells.
Host
ArtNr.
Menge 250 mg
Lieferbar
EBOV/­MARV-­IN-­1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells.
Host
ArtNr.
Menge 100 mg
Lieferbar
EBOV/­MARV-­IN-­1 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. EBOV/MARV-IN-1 is a potent inhibitor of Ebola virus (EBOV) and Marburg virus (MARV), with broad-spectrum activity (EC50=0.31, and 0.82 μM, respectively) and low cytotoxicity (SI>100) in HeLa cells.
Host
ArtNr.
Menge 1 g
Lieferbar
KRAS inhibitor-­9 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. KRAS inhibitor-9, a potent KRAS inhibitor (Kd=92 μM), blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 binds to KRAS G12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells.
Host
ArtNr.
Menge 250 mg
Lieferbar

609594 Artikel

pro Seite